TSPAN4 and pancreatic neoplasm: However, although our study still has some limitations such as the single cell dataset only included 3 clinical cohorts (2 primary cancers, 2 metastatic cancers, and 1 normal tissue), and the detailed molecular mechanism of TSPAN4 in inducing fibroblasts to promote pancreatic cancer progression needs to be further investigated.